Clinical Trial Update: Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the effect of metformin in the prevention of HG in HR-positive, HER2-negative, PIK3CA-mutant advanced breast cancer; the trial status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: MedSIR | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED